NCT02878928 - Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety | Biotech Hunter

Enrollment

579

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

DepressionAnxiety

Interventions

GENETIC

IDgenetix Neuropsychiatric Test Panel

The IDgenetix Neuropsychiatric Test Panel is used to make recommendations on the medication therapy that might be impacted by the genetic background of the patient.

Trial Locations (17)

Unknown

Adnab Research, Rolling Hills

Artemis Clinical Research, San Diego

Adnab Research, Torrance

Collaborative Neuroscience Network, Torrance

Innovative Clinical Research, Lauderhill

Innova Clinical Trials, Miami

APG Research, Orlando

iResearch Atlanta, Decatur

Meridian Clinical Research, Savannah

Medpharmics, Metairie

Meridian Clinical Research, Norfolk

United Medical Associates, Binghamton

Richmond Behavioral Associates, Staten Island

Carolina Partners in Mental HealthCare, Raleigh

Detweiler Family Medicine, Lansdale

Relaro Medical Trials, Dallas

Tidewater Clinical Research, Virginia Beach